If Mannkind isn't going to demand that Sanofi fulfill it's marketing obligations then at least the users of Afrezza need to get the message out!
Is it the same person? I have my doubts.
In the original reference he asks people to contact him at @Tedmann on twitter. The WSJ article writer is @TMannWSJ. These are different twitter handles!
True, however you have to look at it from the perspective of "ignorance is bliss". Mainstream media is still not pushing the story yet because they are largely unaware. The fact that they are covering it is a start. When and if they do follow ups remains to be seen. What Mannkind can do is follow up on the story; reach out to the journalist that wrote it and tell them about Sam, Spiro and everyone else.
that is what I would expect Mannkind's PR department to do.
If pps stays hovering at this price for the next few weeks, shorts are bound to exit. why you ask? because they too are not making any money!
what we have here is STANDOFF; and Matt is right, stay tuned!
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE technology. The Company's proprietary product pipeline is focused on advancing treatments for rare diseases, including PUR1900, a, inhaled anti-fungal for patients with cystic fibrosis (CF) as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. In addition, Pulmatrix is pursuing opportunities in major pulmonary diseases through collaboration with partners. This includes PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD) in collaboration with Mylan N.V., and other potential first-in-class treatments. Pulmatrix's product candidates are based on iSPERSE, its proprietary dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.
I agree that shorts are getting jumpy, yet somehow, as a long I too am getting jumpy. Getting a little tired of "the wait and see"
One needs the patience of a saint to hold this stock!
Don't know, I know Hakan has faced a lot of criticism because he is harder to understand and he's made a few contradictory statements, however Al trust him to run his namesake company as the CEO. Good enough for me. Matt of course is more eloquent in getting his point across,
I however still wish they'd hire a true PR person to attend these with them to clarify some of the statements. The analysts seem to want to eat them alive.
(930 AM EST) Webcast available.
give up.. All you are doing is wasting everyone's time. Let the price rise to where it's worth and maybe just maybe I'll sell you my shares..... NOT!!
Compliments of Dr. Stock.picker
From doctor.stockpicker @yahoo message boards:
What I saw today was almost unbelieveable!!!!
I have several patients on Afrezza and have seen some very good results, but nothing like the patient I saw today. Previously, I thought I would not post patient data here, but this astonished me. This patient has been a diabetic for over 30 years and has profound insulin resistance. His regimen was Lantus 60 units every 12 hours and at least 30 units of prandial insulin with each meal. His finger stick blood sugars were terrible, so we decided to try 16 units of Afrezza in place of his injectable prandial insulin. Today, he was in for an acute care visit concerning another issue, but he brought in his glucose log and it was truly amazing.. The vast majority of his readings were well less then 200 except his readings prior to the evening meal. But the most astounding revelation was that he had stopped taking his morning Lantus. He was ecstatic and so was I. I told him to split his Lantus 30 units every 12 hours to bring his evening sugar down. (Lantus is a lousy once a day basal insulin). Once again, it was astounding.
I know you shorts are going to blast this note, but to prove how much this event has made me believe in Afrezza, I will self bump this daily on the message board until I sell my MNKD years from now. It will be there every day for every one to see and if I'm wrong the detractors will have ample opportunity to tell me so I am absolutely convinced that this will be one of the best selling drugs of all time and I believe every diabetic without contraindications will be using Afrezza